Axitan Limited Appoints Sam Romes as Senior Bioprocessing Engineer
Axitan Limited, a leading biotech company focused on the development of endolysin enzyme products to replace antibiotics in animal feed, is pleased to announce the appointment of Sam Romes as Senior Bioprocessing Engineer. In this role, Sam will oversee the Company’s fermentation processes and technology transfers to Contract Manufacturing Organizations as Axitan expands its global CMO network.
Al Zimmerman, CEO of Axitan, expressed his enthusiasm about Sam’s appointment, stating, “Sam’s extensive experience in large-scale fermentation aligns with Axitan’s vision to enhance commercial sale volumes of our endolysin-based product, FORC3®.”
Sam Romes shared his excitement about joining Axitan, emphasizing the company’s mission to reduce antibiotics in animal feed through innovative endolysin-based solutions.
Endolysins are enzymes with specific antimicrobial activity against targeted pathogens. Axitan’s first feed additive product, FORC3®, targets Clostridium perfringens, the pathogen responsible for necrotic enteritis in poultry.
Sam Romes brings a wealth of experience from his previous roles at alternative food protein company EVERY and Lawrence Berkeley National Laboratory. With a Master’s Degree in Chemical Engineering from the University of Louisville, Sam is well-equipped to drive manufacturing advancements and technology transfers at Axitan.
About Axitan
Axitan is a biotech company dedicated to developing, manufacturing, and selling endolysins to combat pathogens affecting animal production and food safety. Through its innovative technology platform, Axitan aims to usher in a new era of feed additives targeting challenging pathogens without the use of antibiotics. With operations in the US and UK, Axitan is committed to promoting antibiotic-free animal production through endolysin-based solutions. For more information, please visit www.axitan.com.
